Vilacto Bio PEG
Delisted
PEG Ratio (Price/Earnings-to-Growth) of Vilacto Bio (VIBI) as of Jul 31, 2026.
Get this data via API
Financial Data API
PEG
0.00
Last updated:
PEG Ratio (Price/Earnings-to-Growth) of Vilacto Bio is 2026 0.00 . PEG Ratio (Price/Earnings-to-Growth) of Vilacto Bio was 2025 0.00 . It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API
Vilacto Bio Stock analysis
What does Vilacto Bio do? Vilacto Bio Inc is a company that was founded in the USA in 2014. It was founded with the goal of producing natural and high-quality skincare products that support skin health and behave environmentally and ethically responsibly.
The history of Vilacto Bio began when the CEO and founder of the company, Allan Villadsen, started his company with the production of concentrate products for cosmetics. The company was based on his research and discovery of a previously unknown ingredient, namely Lactoactive. This miracle substance could help in the treatment of skin conditions such as acne, psoriasis, and eczema. Vilacto Bio's products quickly experienced success and were praised by many customers and skincare experts worldwide.
Vilacto Bio offers a variety of skincare products, including face creams, face masks, hand creams, body butter, body oils, and lip balms. The company uses only natural ingredients such as aloe vera, propolis, and shea butter to ensure that their products are as gentle as possible on the skin.
Vilacto Bio's skincare products are divided into three different lines - Vilacto Premium Line, Vilacto Medi+ Line, and Vilacto Baby & Kids Line. Vilacto Premium Line is intended for people looking for high-quality and luxurious skincare products. Vilacto Medi+ Line is particularly suitable for people suffering from skin conditions such as psoriasis. Vilacto Baby & Kids Line, on the other hand, is suitable for the delicate and sensitive skin of children and babies.
Vilacto Bio's business model is based on the principles of sustainability and ethical production. The company is committed to producing its products in an environmentally friendly manner and is committed to considering social and environmental conditions in every production. Vilacto Bio demonstrates this through careful selection of suppliers, raw materials, and packaging. The company's goal is to produce products that are not only good for the skin but also good for the environment and society as a whole.
Overall, Vilacto Bio is a company dedicated to the production of natural and skin-friendly cosmetic products. They are passionate, committed, and strive to produce the best possible products for their customers. They believe in sustainability, ethical practices, and global responsibility, and demonstrate this in every aspect of their product manufacturing. Through their ability to combine natural skincare products with innovative formulas and sustainability, they are making a name for themselves as a leading skincare manufacturer worldwide. Vilacto Bio is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Vilacto Bio stock
On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) Vilacto Bio since 2006 – with annual values, charts, and detailed analysis.
Access this data via the Eulerpool API
Valuation — Vilacto Bio
All Key Metrics — Vilacto Bio
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth